Véronique Witko‐Sarsat

16.1k total citations · 3 hit papers
110 papers, 8.9k citations indexed

About

Véronique Witko‐Sarsat is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Véronique Witko‐Sarsat has authored 110 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Immunology, 40 papers in Pulmonary and Respiratory Medicine and 39 papers in Molecular Biology. Recurrent topics in Véronique Witko‐Sarsat's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (34 papers), Vasculitis and related conditions (27 papers) and Dialysis and Renal Disease Management (20 papers). Véronique Witko‐Sarsat is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (34 papers), Vasculitis and related conditions (27 papers) and Dialysis and Renal Disease Management (20 papers). Véronique Witko‐Sarsat collaborates with scholars based in France, United States and Norway. Véronique Witko‐Sarsat's co-authors include Béatrice Descamps‐Latscha, Thao Nguyen‐Khoa, Chantal Capeillère‐Blandin, Paul Jungers, Miriam A. Friedlander, Thu Anh Nguyen, Lise Halbwachs‐Mecarelli, J. Zingraff, Tilman B. Drüeke and Philippe Lesavre and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Véronique Witko‐Sarsat

106 papers receiving 8.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advanced oxidation protein products as a novel marker of oxidative stress in uremia

1996 1.7k citations Véronique Witko‐Sarsat, Thao Nguyen‐Khoa et al. Kidney International profile →
Neutrophils: Molecules, Functions and Pathophysiological Aspects

2000 865 citations Véronique Witko‐Sarsat, Philippe Rieu et al. profile →
Advanced Oxidation Protein Products as Novel Mediators of Inflammation and Monocyte Activation in Chronic Renal Failure,

1998 743 citations Véronique Witko‐Sarsat, Thao Nguyen‐Khoa et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Véronique Witko‐Sarsat France	42	2.4k	2.2k	1.9k	1.7k	1.1k	110	8.9k
L.A.H. Monnens Netherlands	48	1.1k 0.5×	3.7k 1.7×	1.5k 0.8×	1.8k 1.1×	678 0.6×	275	8.7k
Béatrice Descamps‐Latscha France	44	1.4k 0.6×	1.7k 0.7×	1.0k 0.5×	2.7k 1.6×	1.1k 1.0×	97	9.2k
Hidenori Koyama Japan	68	1.5k 0.6×	5.9k 2.6×	1.3k 0.7×	1.8k 1.1×	1.6k 1.4×	414	15.1k
János G. Filep Canada	59	2.8k 1.2×	2.9k 1.3×	1.2k 0.6×	729 0.4×	1.8k 1.6×	196	9.0k
Carla Zoja Italy	69	2.4k 1.0×	3.4k 1.5×	1.2k 0.6×	4.8k 2.8×	2.0k 1.7×	192	13.3k
Gary E. Striker United States	58	1.4k 0.6×	2.2k 1.0×	1.2k 0.6×	3.0k 1.8×	1.8k 1.6×	150	13.5k
Nicholas Topley United Kingdom	61	3.2k 1.4×	2.2k 1.0×	1.6k 0.8×	4.7k 2.8×	708 0.6×	179	11.9k
Anirban Banerjee United States	60	2.3k 1.0×	2.7k 1.2×	1.3k 0.7×	478 0.3×	1.2k 1.1×	288	13.2k
Yoshitaka Isaka Japan	53	1.2k 0.5×	4.1k 1.9×	1.2k 0.7×	4.1k 2.4×	919 0.8×	395	12.2k
Maria F. Lopes‐Virella United States	54	2.7k 1.1×	2.1k 0.9×	564 0.3×	391 0.2×	1.1k 1.0×	225	10.7k

Countries citing papers authored by Véronique Witko‐Sarsat

Since Specialization

Citations

This map shows the geographic impact of Véronique Witko‐Sarsat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Witko‐Sarsat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Witko‐Sarsat more than expected).

Fields of papers citing papers by Véronique Witko‐Sarsat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Véronique Witko‐Sarsat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Witko‐Sarsat. The network helps show where Véronique Witko‐Sarsat may publish in the future.

Co-authorship network of co-authors of Véronique Witko‐Sarsat

This figure shows the co-authorship network connecting the top 25 collaborators of Véronique Witko‐Sarsat. A scholar is included among the top collaborators of Véronique Witko‐Sarsat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Véronique Witko‐Sarsat. Véronique Witko‐Sarsat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kitching, A. Richard, Véronique Witko‐Sarsat, Thorsten Wiech, et al.. (2024). Myeloperoxidase-specific antineutrophil cytoplasmic antibody-associated vasculitis. The Lancet Rheumatology. 6(5). e300–e313. 16 indexed citations

Aymonnier, Karen, Jennifer Amsler, Peter Lamprecht, Alan D. Salama, & Véronique Witko‐Sarsat. (2022). The neutrophil: A key resourceful agent in immune‐mediated vasculitis. Immunological Reviews. 314(1). 326–356. 21 indexed citations

London, Jonathan, Sébastien Lofek, Jérémie Dion, et al.. (2020). Skewed peripheral B- and T-cell compartments in patients with ANCA-associated vasculitis. Lara D. Veeken. 60(5). 2157–2168. 8 indexed citations

Thiéblemont, Nathalie, Véronique Witko‐Sarsat, & Amiram Ariel. (2018). Regulation of macrophage activation by proteins expressed on apoptotic neutrophils: Subversion towards autoimmunity by proteinase 3. European Journal of Clinical Investigation. 48(S2). e12990–e12990. 20 indexed citations

Hadjadj, Jérôme, Guillaume Canaud, Tristan Mirault, et al.. (2018). mTOR pathway is activated in endothelial cells from patients with Takayasu arteritis and is modulated by serum immunoglobulin G. Lara D. Veeken. 57(6). 1011–1020. 35 indexed citations

Witko‐Sarsat, Véronique & Sylvain Perruche. (2016). La protéinase 3. médecine/sciences. 32(5). 450–452.

Martin, Katherine, Chahrazade Kantari‐Mimoun, Min Yin, et al.. (2016). Proteinase 3 Is a Phosphatidylserine-binding Protein That Affects the Production and Function of Microvesicles. Journal of Biological Chemistry. 291(20). 10476–10489. 39 indexed citations

Martin, Katherine, et al.. (2015). Promoting apoptosis of neutrophils and phagocytosis by macrophages: novel strategies in the resolution of inflammation. Swiss Medical Weekly. 145(708). w14056–w14056. 32 indexed citations

Martin, Clémence, Julie Mocek, Magali Pederzoli-Ribeil, et al.. (2015). Neutrophil-Expressed p21/waf1 Favors Inflammation Resolution in Pseudomonas aeruginosa Infection. American Journal of Respiratory Cell and Molecular Biology. 54(5). 740–750. 17 indexed citations

10.

Millet, Arnaud, Magali Pederzoli-Ribeil, Pascale Tacnet‐Delorme, et al.. (2012). Proteinase 3, the Autoantigen in Granulomatosis with Polyangiitis, Associates with Calreticulin on Apoptotic Neutrophils, Impairs Macrophage Phagocytosis, and Promotes Inflammation. The Journal of Immunology. 189(5). 2574–2583. 55 indexed citations

11.

Dib, Hanadi, Mathieu C. Tamby, Guillaume Bussone, et al.. (2011). Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma. European Respiratory Journal. 39(6). 1405–1414. 73 indexed citations

12.

Kantari, Chahrazade, et al.. (2005). Proteinase-3 Induces Procaspase-3 Activation in the Absence of Apoptosis: Potential Role of this Compartmentalized Activation of Membrane-Associated Procaspase-3 in Neutrophils,. The Journal of Immunology. 174(10). 6381–6390. 31 indexed citations

13.

Dublet, Bernard, Antonella Ruello, Eric Hajjar, et al.. (2005). Cleavage of p21/WAF1/CIP1 by Proteinase 3 Modulates Differentiation of a Monocytic Cell Line. Journal of Biological Chemistry. 280(34). 30242–30253. 22 indexed citations

14.

Witko‐Sarsat, Véronique, Valérie Gausson, & Béatrice Descamps‐Latscha. (2003). Are advanced oxidation protein products potential uremic toxins?. Kidney International. 63(84). S11–S14. 90 indexed citations

15.

Witko‐Sarsat, Véronique, et al.. (2002). Cleavage of p21 by Proteinase-3, a Myeloid-specific Serine Protease, Potentiates Cell Proliferation. Journal of Biological Chemistry. 277(49). 47338–47347. 41 indexed citations

16.

Halbwachs‐Mecarelli, Lise, Véronique Witko‐Sarsat, Philippe Rieu, Béatrice Descamps‐Latscha, & Philippe Lesavre. (2001). Neutrophil biology in relation to renal diseases.. PubMed. 31. 153–71.

17.

Nguyen‐Khoa, Thao, Ziad A. Massy, Véronique Witko‐Sarsat, et al.. (1999). Oxidized Low-Density Lipoprotein Induces Macrophage Respiratory Burst via Its Protein Moiety: A Novel Pathway in Atherogenesis?. Biochemical and Biophysical Research Communications. 263(3). 804–809. 64 indexed citations

18.

Witko‐Sarsat, Véronique, Robert C. Allen, Marc Paulais, et al.. (1996). Disturbed myeloperoxidase-dependent activity of neutrophils in cystic fibrosis homozygotes and heterozygotes, and its correction by amiloride. The Journal of Immunology. 157(6). 2728–2735. 88 indexed citations

19.

Ward, Peter A., Ann Arbor, Jay A. Nadel, et al.. (1996). Inflammation in Cystic Fibrosis. Mediators of Inflammation. 5(2). 121–143. 1 indexed citations

20.

Witko‐Sarsat, Véronique, et al.. (1995). Neutrophil-Derived Long-Lived Oxidants in Cystic Fibrosis Sputum. American Journal of Respiratory and Critical Care Medicine. 152(6). 1910–1916. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact